Literature DB >> 31292665

Use of psychosocial services by lung cancer survivors in Germany : Results of a German multicenter study (LARIS).

Martin Eichler1,2,3, Marlene Hechtner4,5, Beatrice Wehler6,7, Roland Buhl7, Jan Stratmann8, Martin Sebastian8, Heinz Schmidberger9, Cornelius Kortsik10, Ursula Nestle11,12, Hubert Wirtz13, Thomas Wehler14, Maria Blettner4, Susanne Singer4.   

Abstract

PURPOSE: Little is known about the use of psychosocial services in lung cancer survivors and patients who have survived the diagnosis for at least one year. We investigated the frequency of use, stratified by radiation therapy received, its associated factors, and the reasons for non-use of those services.
METHODS: We performed a multicenter (n = 6 hospitals) cross-sectional study using data from medical records, patient reported questionnaires, and computer-assisted telephone interviews. Odds ratios (OR) for factors potentially associated with the use of any type of psychosocial services were calculated using multivariable logistic regression.
RESULTS: We included 604 lung cancer patients/survivors. Of them, 60% (69% of those who had received radiotherapy) had used some kind of psychological and/or social service in the past (47% psychological, 42% social); 39% had used inpatient care, 24% outpatient care (cancer counselling center, general counselling center, psychological counselling by family doctor, psychotherapy, patient support group, pastoral work). Of those who visited a rehabilitation clinic, 66% received psychosocial care there. Factors associated with using psychosocial services in general were female gender (OR 1.96, 95% CI 1.32-2.93), poor emotional functioning (per unit decrease: OR 0.99, 95% CI 0.98-0.996), and younger age (per year decrease: OR 0.95, 95% CI 0.93-0.97). CONCLUSIONS/IMPLICATIONS: The high proportion of psychosocial care users among lung cancer survivors in Germany indicates that patients are interested in using it and that an unmet need exists. The creation of a broad spectrum of easily accessible services with high quality is important to enable and facilitate use.

Entities:  

Keywords:  Cancer survivorship; Lung cancer; Psycho-oncology; Psychosocial care; Psychosocial services

Mesh:

Year:  2019        PMID: 31292665     DOI: 10.1007/s00066-019-01490-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

1.  [Radiotherapy enhances the effect of PD-1 checkpoint inhibitors].

Authors:  René Baumann; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2017-09       Impact factor: 3.621

Review 2.  Evidence-practice gaps in lung cancer: A scoping review.

Authors:  N M Rankin; D McGregor; E Stone; P N Butow; J M Young; K White; T Shaw
Journal:  Eur J Cancer Care (Engl)       Date:  2016-10-13       Impact factor: 2.520

Review 3.  Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients.

Authors:  Harald Baumeister; Katrin Balke; Martin Härter
Journal:  J Clin Epidemiol       Date:  2005-08-15       Impact factor: 6.437

4.  Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress.

Authors:  Kristi D Graves; Susanne M Arnold; Celia L Love; Kenneth L Kirsh; Pamela G Moore; Steven D Passik
Journal:  Lung Cancer       Date:  2006-11-03       Impact factor: 5.705

5.  Trends in non-help-seeking for mental disorders in Germany between 1997-1999 and 2009-2012: a repeated cross-sectional study.

Authors:  Susanne Brandstetter; Frank Dodoo-Schittko; Sven Speerforck; Christian Apfelbacher; Hans-Jörgen Grabe; Frank Jacobi; Ulfert Hapke; Georg Schomerus; Sebastian E Baumeister
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-04-29       Impact factor: 4.328

6.  Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany.

Authors:  Joachim Weis; Klaus Hönig; Corinna Bergelt; Hermann Faller; Anette Brechtel; Beate Hornemann; Barbara Stein; Martin Teufel; Ute Goerling; Yesim Erim; Franziska Geiser; Alexander Niecke; Bianca Senf; Martin Wickert; Claudia Schmoor; Angelika Gerlach; Dieter Schellberg; Antje Büttner-Teleaga; Katharina Schieber
Journal:  Psychooncology       Date:  2018-10-19       Impact factor: 3.894

7.  [Utilisation of Psycho-oncological Services in Hospitals and Outpatient Counselling Centres by Survivors of Breast, Colon and Prostate Cancer].

Authors:  Sylke Ruth Zeissig; Susanne Singer; Lena Koch; Maria Blettner; Volker Arndt
Journal:  Psychother Psychosom Med Psychol       Date:  2014-12-08

8.  Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries.

Authors: 
Journal:  BMC Med       Date:  2017-01-13       Impact factor: 8.775

9.  Cancer patients' wish for psychological support during outpatient radiation therapy : Findings from a psychooncological monitoring program in clinical routine.

Authors:  D Riedl; R Gastl; E Gamper; C R Arnold; D Dejaco; F Schoellmann; G Rumpold
Journal:  Strahlenther Onkol       Date:  2018-03-12       Impact factor: 3.621

10.  Factors Associated with Depression Assessed by the Patient Health Questionnaire-2 in Long-Term Cancer Survivors.

Authors:  Ae-Jin Goo; Yun-Mi Song; Jinyoung Shin; Hyeonyoung Ko
Journal:  Korean J Fam Med       Date:  2016-07-21
View more
  2 in total

1.  Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study.

Authors:  Susanne Singer; Wolfgang Janni; Thorsten Kühn; Felix Flock; Ricardo Felberbaum; Lukas Schwentner; Elena Leinert; Achim Wöckel; Tanja Schlaiß
Journal:  Arch Gynecol Obstet       Date:  2022-07-15       Impact factor: 2.493

2.  Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial.

Authors:  Mirjam Renovanz; Melina Hippler; Martin Voss; Jens Wehinger; Almuth F Keßler; Jens Gempt; Minou Nadji-Ohl; Carolin Weiß Lucas; Marion Rapp; Martin Misch; Jan Coburger; Marcus Mehlitz; Jürgen Meixensberger; Naureen Keric; Ghazaleh Tabatabai; Maria Blettner; Melanie Schranz; Susanne Singer
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.